Bafna Pharmaceuticals Limited (NSE:BAFNAPH)

Bafna Pharmaceuticals Revenue

Bafna Pharmaceuticals had revenue of 382.86M INR in the quarter ending December 31, 2025, with 15.36% growth. This brings the company's revenue in the last twelve months to 1.47B, down -0.51% year-over-year. In the fiscal year ending March 31, 2025, Bafna Pharmaceuticals had annual revenue of 1.46B, down -4.33%.

• Revenue (ttm): 1.47B
• Revenue Growth: -0.51%
• P/S Ratio: 1.99
• Revenue / Employee: 3.63M
• Employees: 406
• Market Cap: 2.93B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	1.46B	-66.09M	-4.33%
Mar 31, 2024	1.52B	371.16M	32.18%
Mar 31, 2023	1.15B	302.10M	35.48%
Mar 31, 2022	851.40M	139.22M	19.55%
Mar 31, 2021	712.18M	287.45M	67.68%